Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have high blood pressure that remains uncontrolled despite taking three or more blood pressure medications (including a water tablet, if tolerated) at the highest appropriate doses, confirmed by a 24-hour blood pressure monitoring test, with an average daytime reading of 130 mmHg or higher after medications are given by a nurse.
- People who have high blood pressure but cannot tolerate their blood pressure medications due to side effects, confirmed by a 24-hour blood pressure monitoring test showing an average reading of 130 mmHg or higher after medications are given by a nurse.
- People whose kidney function has been getting noticeably worse over time (declining by more than a certain amount per year) and who have narrowing in the arteries supplying both kidneys, or narrowing in the artery supplying a single remaining kidney.
- People who have had repeated episodes of sudden heart failure or fluid on the lungs, combined with hard-to-control high blood pressure (on three or more medications at optimal doses), where no other clear cause has been found, and whose average 24-hour blood pressure reading is 130 mmHg or higher after nurse-administered medications.
- People under 40 years of age who have high blood pressure confirmed by a 24-hour monitoring test showing an average reading of 130/80 mmHg or higher after medications are given by a nurse.
- People whose scan results (such as an ultrasound or kidney scan) suggest a significant narrowing of one or more arteries supplying the kidneys.
- People whose CT scan or specialised X-ray of the kidney arteries shows a narrowing of 70% or more in at least one artery supplying the kidneys.
Who may not be able to join:
- People who have significant narrowing in the arteries supplying both kidneys, but where only one side is planned to be treated during the procedure.
- People where the kidney being treated receives 10% or less of the total kidney function (measured without certain blood pressure medications) and that kidney is smaller than 7 cm in length.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +45 7845 2455
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in 24-hour ambulatory systolic and diastolic blood pressures from baseline to 24 months after PTRA in patients with 24-hour ambulatory average systolic blood pressure ≥ 150 mmHg at baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.